Keyphrases
Non-Hodgkin Lymphoma
100%
Hodgkin Disease
100%
High-dose Chemotherapy
100%
Hodgkin
50%
Radiotherapy
25%
High Risk
25%
Chemosensitivity
25%
Long-term Survival
25%
Intensive Care Medicine
25%
Relapsed Disease
25%
Treatment Choice
25%
Refractory Disease
25%
Lymphoma Patients
25%
Relapsed or Refractory
25%
Autologous Stem Cell Rescue
25%
Initial Treatment
25%
Dose-intensive
25%
Suboptimal Response
25%
Durable Response
25%
Combination Chemotherapy
25%
Indolent non-Hodgkin Lymphoma
25%
Salvage Therapy
25%
International Prognostic Index
25%
Long-term Disease-free Survival
25%
Investigative Approach
25%
Medicine and Dentistry
High Dose Chemotherapy
100%
Hodgkin's Lymphoma
100%
Non-Hodgkin Lymphoma
100%
Diseases
20%
Transplantation
20%
Disease Free Survival
20%
Radiation Therapy
20%
Long Term Survival
20%
Combination Chemotherapy
20%
Chemosensitivity
20%
Salvage Therapy
20%
International Prognostic Index
20%
Stem Cell
20%
Immunology and Microbiology
Drug Megadose
100%
Chemosensitivity
25%
Stem Cell
25%
Long Term Survival
25%
Disease Free Survival
25%